首页> 外文会议>International Conference on Artificial Intelligence in Medicine >Transforming Healthcare with Artificial Intelligence - Lessons from Ophthalmology (Abstract of Invited Talk)
【24h】

Transforming Healthcare with Artificial Intelligence - Lessons from Ophthalmology (Abstract of Invited Talk)

机译:用人工智能改造医疗保健 - 眼科课程(邀请谈话摘要)

获取原文

摘要

Ophthalmology is among the most technology-driven of the all the medical specialties, with treatments utilizing high-spec medical lasers and advanced microsurgical techniques, and diagnostics involving ultra-high resolution imaging. Ophthalmology is also at the forefront of many trailblazing research areas in healthcare, such as stem cell therapy, gene therapy, and - most recently - artificial intelligence. In July 2016, Moorfields announced a formal collaboration with the artificial intelligence company, DeepMind. This collaboration involves the sharing of > 1,000,000 anonymised retinal scans with DeepMind to allow for the automated diagnosis of diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DR). In my presentation, I will describe the motivation - and urgent need - to apply deep learning to ophthalmology, the processes required to establish a research collaboration between the National Health Service (NHS) and a company like DeepMind, the initial results of our research, and finally, why I believe that ophthalmology could be first branch of medicine to be fundamentally reinvented through the application of artificial intelligence.
机译:眼科是所有医学专业的技术驱动,采用高规格医疗激光器和先进的显微外科技术,以及涉及超高分辨率成像的诊断。眼科也处于医疗保健的许多小型开拓者研究领域的最前沿,例如干细胞疗法,基因治疗,最近 - 最近 - 人工智能。 2016年7月,Moorfields宣布与人工智能公司DeepMind的正式合作。该协作涉及与DeepMind共享> 1,000,000次匿名视网膜扫描,以便允许自动诊断与年龄相关的黄斑变性(AMD)和糖尿病视网膜病变(DR)等疾病的自动诊断。在我的演讲中,我将描述动机 - 迫切需要 - 为眼科进行深度学习,所需的流程在国家卫生服务(NHS)和一家公司中建立研究合作,如Deepmind,我们的研究初步结果,最后,为什么我认为眼科可能是通过应用人工智能的基本上重新发明的第一个药物的分支。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号